Upcoming webinars

Dr. Luke Jostins-Dean is the Principal Scientist at Nightingale Health, and an Associate Professor and group leader at the Kennedy Institute of Rheumatology at the University of Oxford. His research focuses on developing statistical approaches to leverage genetic, metagenomic and metabolomic profiling to understand and predict the onset and progression of common diseases. His research into the genetics inflammatory bowel disease and other inflammatory conditions has been highly influential and widely cited, with recent work focusing on predicting response to treatment in inflammatory disease from host and microbiome genetics, understanding the osteoarthritis pathogenesis using proteomics, and predicting the onset of common diseases in healthy individuals from metabolomics.

Dr. Mattia Cordioli is a Senior Data Scientist at Nightingale Health. He completed his PhD in Population Health in 2024 at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland. In his doctoral work, which was selected as one of the four best thesis of the year in Finland, he worked with large-scale biobank data, contributing to the largest global study on the genetics of COVID-19, exploring participation bias in biobank-based studies and how genetic and socio-demographic factors jointly influence medication adherence.